Burden of liver disease in the United States: Summary of a workshop

Hepatology

Volumn 36, Issue 1, 2002, Pages 227-242

  Kim, W Ray ^a   Brown, Robert S ^b   Terrault, Norah A ^c   El Serag, Hashem ^d  

^a MAYO CLINIC   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA2B INTERFERON; REBETRON; RIBAVIRIN;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; AUTOIMMUNE DISEASE; CHOLELITHIASIS; DRUG COST; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC PREDISPOSITION; HEALTH CARE COST; HEALTH ECONOMICS; HEPATITIS C; HUMAN; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; METABOLIC DISORDER; POPULATION RESEARCH; PORTAL HYPERTENSION; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES; VIRUS HEPATITIS;

EID: 18444393386     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.34734     Document Type: Article

References (72)

1. The epidemiology of newly-diagnosed chronic liver disease in the United States: Findings of population-based sentinel surveillance
2. Rising incidence of hepatocellular carcinoma in the United States
3. Health spending growth up in 1999: Faster growth expected in the future
4. Costs of diabetes. A methodological analysis of the literature
5. Who drinks most of the alcohol in the US? The policy implications
6. Prevalence of DSMIV alcohol abuse and dependence in United States 1992
7. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
8. Etiopathogenesis of nonalcoholic steatohepatitis
9. Nonalcoholic fatty liver disease: The most common cause of abnormal liver enzymes in the US population
10. Clinical features and natural history of nonalcoholic stearosis syndromes
11. Cryprogenic cirrhosis: Clinical characterization and risk factors for underlying disease
12. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
13. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease
14. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases
15. The natural history of nonalcoholic fatty liver: A follow-up study
16. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
17. Treatment of nonalcoholic fatty liver: Present and emerging therapies
18. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
19. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
20. The long-term pathological evolution of chronic hepatitis C
21. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
22. The long-term outcomes of patients with compensated hepatitis C virusrelated cirrhosis and history of parenteral exposure in the United States
23. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study
24. Clinical outcome of hepatitis C as a function of mode of transmission
25. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
26. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
27. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994
28. Incidence of hepatitis B virus infection in the United States, 1976-1994: Estimates from the National Health and Nutrition Examination Surveys
29. The impact of liver transplantation and ursodeoxycholic acid on mortality and hospital service utilization in patients with primary biliary cirrhosis in the US
30. Transplantation for primary biliary cirrhosis: Retrospective analysis of 400 patients in a single center
31. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis
32. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population
33. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
34. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
35. Global prevalence of putative haemochromatosis mutations
36. A population-based study of the clinical expression of the hemochromatosis gene
37. Clinical features of genetic hemochromatosis in women compared with men
38. Hemochromatosis-associated mortality in the United States from 1979 to 1992: An analysis of multiple-cause mortality data
39. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
40. EASL international consensus conference on haemochromatosis
41. Genetic liver disease in adults. Early recognition of the three most common causes
42. Wilson's disease with severe hepatic insufficiency: Beneficial effects of early administration of D-penicillamine
43. Orthotopic liver transplantation for Wilson's disease: A single-center experience
44. Liver transplantation for Wilson's disease: A single-center experience
45. Liver disease in infancy and childhood
46. Use of liver transplantation in patients with acute liver failure
47. Etiology and outcome for 295 patients with acute liver failure in the United States
48. Fulminant hepatitis: Mayo Clinic experience with 34 cases
49. The American experience with transplantation for acute liver failure
50. Acetaminophen toxicity in an urban county hospital
51. Risk factors for the rising rates of primary liver cancer in the United States
52. Cancer Statistics, 2001
53. Chronic liver disease and cirrhosis
54. Survival and prognostic indicators in compensated and decompensated cirrhosis
55. Prevalence and ethnic differences in gallbladder disease in the United States
56. Gallstones
57. The transmission, natural history and treatment of hepatitis C virus infection in the pediatric age population
58. Predictors of costs of liver transplantation in children: A single center study
59. Biliary atresia: Summary of a symposium
60. Biliary atresia: Pathogenesis and treatment
61. Long-term outcome after surgery for biliary arresia: Study of 40 patients surviving for more than 10 years
62. Fulminant hepatic failure in children
63. The chronic disease of childhood obesity: The sleeping giant has awakened
64. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents